Cold Agglutinin Disease and COVID-19: A Scoping Review of Treatments and Outcomes

CONCLUSIONS: This review found no increased risk of severe outcomes in CAD and COVID-19 patients treated with rituximab.PMID:38327389 | PMC:PMC10846489 | DOI:10.14740/jocmr5102

Source: Clin Med Res - February 8, 2024 Category: Research Authors: Jackson S Musuuza Silpa Kumar Dheeraj Kumar Posa Aakash Hans Sankett Nayyar Leslie Christensen Gilbert-Roy Kamoga Source Type: research